On the mechanism of antithrombotic action of flavonoids.
暂无分享,去创建一个
R. Gryglewski | R. Korbut | R J Gryglewski | R Korbut | J Robak | J Swies | R. Gryglewski | J. Świȩs | J. Robak | J. Swies
[1] R. Gryglewski,et al. Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities. , 1983, Biochemical pharmacology.
[2] R. Gryglewski,et al. Binding of the membrane active drugs to bovine serum albumin and human erythrocyte membranes. , 1975, Biochemical pharmacology.
[3] K. Sekiya,et al. Selective inhibition of platelet lipoxygenase by baicalein. , 1982, Biochemical and biophysical research communications.
[4] A. Dembińska-kieć,et al. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. , 1978, Atherosclerosis.
[5] L. Cavallini,et al. Comparative evaluation of antiperoxidative action of silymarin and other flavonoids. , 1978, Pharmacological research communications.
[6] H. Jha,et al. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. , 1985, Biochemical pharmacology.
[7] D. Aharony,et al. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. , 1982, Biochimica et biophysica acta.
[8] F. Bruchhausen,et al. Hemmung der Prostaglandinsynthetase durch Flavonoide und Phenolderivate im Vergleich mit deren O2−•‐Radikalfänger‐eigenschaften , 1980 .
[9] M. Steiner,et al. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. , 1984, Biochemical pharmacology.
[10] S. Moncada,et al. An improved method for washing of human platelets with prostacyclin. , 1983, Thrombosis research.
[11] W. Lands. Interactions of lipid hydroperoxides with eicosanoid biosynthesis. , 1985, Journal of free radicals in biology & medicine.
[12] J. Baumann,et al. Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. , 1980, Prostaglandins.
[13] M. Steiner,et al. Inhibition in vitro of platelet aggregation and arachidonic acid metabolism by flavone. , 1984, Biochemical pharmacology.
[14] J. Robak,et al. The influence of chlorpromazine on lipoxidases. , 1980, Biochimica et biophysica acta.
[15] J. Vane,et al. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. , 1976, Prostaglandins.
[16] M. Ishikawa,et al. Endothelium‐dependent inhibition of platelet aggregation , 1986, British journal of pharmacology.
[17] R. C. Dirks,et al. The role of lipid, free radical initiator, and oxygen on the kinetics of lipid peroxidation. , 1982, Toxicology and applied pharmacology.
[18] S. Moncada,et al. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.
[19] A. Marcus,et al. Superoxide production and reducing activity in human platelets. , 1977, The Journal of clinical investigation.
[20] C. Fiedler-Nagy,et al. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. , 1983, Biochemical pharmacology.